Supplements are being recalled because they contain prescription diabetes drugs that could have fatal side effects.

Glucagon-like peptide 1 receptor agonists and fenofibrates may protect patients with type 2 diabetes against diabetic macular ...

By managing insulin resistance with medications, diet, and exercise, you may be able to avoid diabetes as well as complications of thyroid disease. By managing hyperthyroidism with medications, diet, ...

A drug known as digoxin (Digitek, Lanoxin) belongs to a class of medications called digitalis glycosides. This drug helps strengthen heart contractions. Doctors often prescribe it as a regular ...

The main goal of treatment for all types of diabetes insipidus is to relieve thirst and decrease urine production. Typically, treatment for most types of diabetes insipidus in both adults and ...

While age is a factor, certain medications like Benadryl, opiates, and omeprazole, if used long-term, might increase dementia risk. Always consult your doctor before making medication changes.

The medications − part of a class of drugs called GLP-1, or glucagon-like peptide-1, receptor agonists − were first used to treat diabetes but have since been approved for obesity, which has ...

Common prescription and over-the-counter drugs could be unknowingly increasing your risk of dementia, a doctor has warned. The disorder blights the lives of millions worldwide, slowly robbing ...

Medicare, the federal health program for adults 65 and older, has been prohibited by law from covering weight loss drugs for older Americans who are obese but do not have diabetes or heart disease.

The findings indicate the medications might reduce the risk of kidney deterioration and failure, regardless of whether or not somebody has diabetes. According to the research, the combined ...

But while the benefits of GLP-1 receptor agonists for the treatment of type 2 diabetes, obesity and cardiovascular disease are well known, their impact on chronic kidney disease (CKD) has been ...

The primary exposure measured was the use of individual GLP-1 receptor agonists — commonly used to treat type 2 diabetes and obesity ... examined was the use of medications indicated for ...